TRPC channels blockade abolishes endotoxemic cardiac dysfunction by hampering intracellular inflammation and Ca 2+ leakage.
Na TangWen TianGuang-Yuan MaXiong XiaoLei ZhouZe-Zhi LiXiao-Xiao LiuChong-Yao LiKe-Han WuWenjuan LiuXue-Ying WangYuan-Yuan GaoXin YangJian-Zhao QiDing LiYang LiuWen-Sheng ChenJinming GaoXiao-Qiang LiWei CaoPublished in: Nature communications (2022)
Intracellular Ca 2+ dysregulation is a key marker in septic cardiac dysfunction; however, regulation of the classic Ca 2+ regulatory modules cannot successfully abolish this symptom. Here we show that the knockout of transient receptor potential canonical (TRPC) channel isoforms TRPC1 and TRPC6 can ameliorate LPS-challenged heart failure and prolong survival in mice. The LPS-triggered Ca 2+ release from the endoplasmic reticulum both in cardiomyocytes and macrophages is significantly inhibited by Trpc1 or Trpc6 knockout. Meanwhile, TRPC's molecular partner - calmodulin - is uncoupled during Trpc1 or Trpc6 deficiency and binds to TLR4's Pococurante site and atypical isoleucine-glutamine-like motif to block the inflammation cascade. Blocking the C-terminal CaM/IP3R binding domain in TRPC with chemical inhibitor could obstruct the Ca 2+ leak and TLR4-mediated inflammation burst, demonstrating a cardioprotective effect in endotoxemia and polymicrobial sepsis. Our findings provide insight into the pathogenesis of endotoxemic cardiac dysfunction and suggest a novel approach for its treatment.
Keyphrases
- vascular smooth muscle cells
- oxidative stress
- heart failure
- inflammatory response
- left ventricular
- endoplasmic reticulum
- toll like receptor
- angiotensin ii
- intensive care unit
- immune response
- type diabetes
- risk assessment
- anti inflammatory
- metabolic syndrome
- high frequency
- transcription factor
- adipose tissue
- atrial fibrillation
- replacement therapy
- single molecule
- smoking cessation
- patient reported
- free survival